SINOVAC BIOTECH LTD (SVA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2013: $5.58M2014: -$10.13M2015: $4.21M2016: -$13.90M2017: $59.76M2018: $7.94M2019: $39.07M2020: $479.31M2021: $15.32B2022: -$798.12M2023: $138.65M2024: -$56.89M2025: -$512.18M-$512.18M
2013Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$512.18M-800.3%
2024-$56.89M-141.0%
2023$138.65M+117.4%
2022-$798.12M-105.2%
2021$15.32B+3096.7%
2020$479.31M+1126.7%
2019$39.07M+391.9%
2018$7.94M-86.7%
2017$59.76M+529.8%
2016-$13.90M-430.1%
2015$4.21M+141.6%
2014-$10.13M-281.6%
2013$5.58M